Table 1.
Baseline characteristics included patients.
| Characteristics | All patients (n = 40) | Women (n = 16) | Men (n = 24) | P value |
| Age (years) | 69 (64–75) | 68 (63–74) | 71 (66–78) | .17 |
| Ethnicity | ||||
| Arab | 1/40 (3%) | 1/16 (6%) | 0/24 (0%) | .4 |
| Black | 5/40 (13%) | 5/16 (31%) | 0/24 (0%) | .007 |
| South Asian | 1/40 (3%) | 1/16 (6%) | 0/24 (0%) | .4 |
| West Asian | 1/40 (3%) | 1/16 (6%) | 0/24 (0%) | .4 |
| Latin America | 2/40 (5%) | 2/16 (13%) | 0/24 (0%) | .15 |
| White | 27/40 (68%) | 3/16 (19%) | 24/24 (100%) | <.001 |
| Co-morbid conditions | ||||
| Chronic heart disease | 12/40 (30%) | 3/16 (19%) | 9/24 (38%) | .18 |
| Hypertension | 22/40 (55%) | 11/16 (69%) | 11/24 (46%) | .13 |
| Chronic neurological disorder | 8/40 (20%) | 1/16 (6%) | 7/24 (29%) | .08 |
| Obesity | 14/40 (35%) | 9/16 (56%) | 5/24 (21%) | .02 |
| Diabetes with complications | 2/40 (5%) | 0/16 (0%) | 2/24 (8%) | .51 |
| Diabetes w/o complications | 10/40 (25%) | 5/16 (31%) | 5/24 (21%) | .48 |
| Laboratory results | ||||
| White blood cell count (109/L) | 7.2 (6.2–11.0) | 7.2 (6.1–10.5) | 7.1 (6.0–12.9) | .94 |
| Lymphocyte count (109/L) | 0.9 (0.72–1.2) | 0.89 (0.74–1.4) | 0.92 (0.68–1.2) | .90 |
| Neutrophil count (109/L) | 5.7 (4.6–9.2) | 5.85 (4.8–9.0) | 5.4 (4.5–11.4) | .84 |
| Platelets (109/L) | 231 (191–279) | 236 (206–288) | 223 (169–261) | .24 |
| PT (seconds; n = 11) | 11.5 (10.7–12.5) | 11.5 (10.8–28.8) | 12.0 (10.6–12.6) | .93 |
| aPTT (seconds; n = 14) | 29.0 (27.8–33.8) | 26.0 (24.0–33.0) | 30.0 (26.5–34.5) | .71 |
| ALAT (units/L) | 23.5 (16.3–38.0) | 21.5 (15.5–36.8) | 26.0 (17.3–47.0) | .60 |
| ASAT (units/L) | 38.0 (30.0–55.5) | 42.0 (32.5–55.5) | 36.5 (26.3–58.0) | .46 |
| Total bilirubin (μmol/L) | 9.0 (7.0–10.0) | 8.0 (5.3–10.0) | 9.0 (7.5–11.0) | .20 |
| Glucose (mmol/L) | 7.5 (6.5–9.3) | 7.3 (6.7–9.1) | 8.0 (6.3–9.7) | .75 |
| Creatinine (μmol/L) | 90.0 (70.5–125.0) | 76.0 (63.5–120.5) | 92.0 (79.8–128.5) | .16 |
| CRP (mg/L) | 110.6 (71.1–189.7) | 91.9 (65.8–117–5) | 139.2 (82.1–198.1) | .085 |
| CK (units/L) | 123.5 (70.5–228.8) | 206.0 (76.5–314.8) | 103.0 (55.5–180.3) | .25 |
| LDH (units/L) | 428.5 (322.3–511.0) | 469.5 (387.3–608.8) | 371.5 (256.0–470.5) | .56 |
| D-dimer (mg/L) | 1.01 (0.51–1.87) | 1.01 (0.61–2.09) | 0.86 (0.30–1.87) | 1.00 |
| Admission details | ||||
| ICU admission | 15/40 (38%) | 4/16 (25%) | 11/24 (46%) | .32 |
| Invasive ventilation | 14/40 (35%) | 4/16 (25%) | 10/24 (42%) | .33 |
| Deceased | 20/40 (50%) | 7/16 (44%) | 13/24 (54%) | .75 |
Values are n/N(%) or median (IQR).
ALAT = alanine aminotransferase, aPTT = activated partial-thrombine time, ASAT = aspartate aminotransferase, CK = creatine kinase, CRP = C-reactive protein, ICU = intensive care unit, IQR = interquartile range, LDH = lactate dehydrogenase, PT = prothrombine time.